extract in the YPD medium stimulates the invasive growth response (4) . Invasive growth was assayed by washing under a stream of tap water.
For galactose inductions, yeast cells were grown in SCS (synthetic complete sucrose) media to OD 600 0.2, then induced with 2% galactose (final concentration), incubated at 30 °C for 4 hours, centrifuged at 1600g for 2 minutes at 4 °C, and frozen in liquid nitrogen. Yeast lysates were prepared and western blots were performed as described above for starvation assays.
Quantitative and qualitative (patch) yeast mating assays were performed in YPD media as described (10) using a MATα his1 mating tester (1). Quantitative mating efficiency was calculated from the titer of a/α cells divided by the titer of a cells.
Protein Expression and Purification
Constructs to express recombinant proteins were from previous work (11) or were generated by standard molecular biology methods. We used a catalytically-dead allele of Fus3 (K42R) in order to eliminate background autophosphorylation that is observed with the wild-type protein. For kinetic characterization, Ste5 constructs were expressed as maltose binding protein (MBP) fusions.
Fus3 and Ste5 constructs were expressed in Rosetta (DE3) pLysS E. coli cells by inducing with 0.5 mM IPTG overnight at 18 °C. Fus3 K42R was expressed using the pBH4 vector, a derivative of pET15 (Novagen) that was modified to produce an Nterminal His 6 -tagged, TEV-cleavable protein. Full length Ste5 and truncation mapping constructs were expressed with an N-terminal TEV-cleavable MBP and a C-terminal Histag. For Ste5∆(544-592) and all other internal truncations ( Fig. 3A and fig. S9 ), the deleted residues were replaced with a 5X(GAGS) linker. Ste5-ms (the minimal VWA domain, residues 593-786), the Ste5 PH domain fragment (Fig. 3E) , and the Ste5 582-786 fragment used for crystallography were expressed from the pBH4 vector.
Constructs expressed from pBH4 were affinity purified on Ni-NTA (Qiagen), cleaved with TEV protease to release the N-terminal His 6 tag, and further purified by ion exchange (RESOURCE 15Q [Amersham], 20 mM Tris·HCl pH 8.0, 2 mM DTT, 10% glycerol, and 0-1 M NaCl). Constructs expressed from pMBP were affinity purified on Ni-NTA (Qiagen), followed by amylose resin (New England Biolabs). Purified proteins were dialyzed into 20 mM Tris Tris·HCl pH 8.0, 150 mM NaCl, 10% glycerol, and 2 mM DTT at 4 °C, aliqouted and stored at -80 °C.
Ste7 (constitutively active Ste7EE, bearing S359E and T363E phosphomimic mutations in the activation loop (11, 12) ) and Ste11 (wild type) were expressed with an N-terminal TEV-cleavable MBP and C-terminal His-tag in Spodoptera frugiperda (SF9) cells, using the Bac-to-Bac Baculoviral Expression System (Life Technologies) at 27 °C. Proteins were affinity purified on Ni-NTA (Qiagen), followed by amylose resin (New England Biolabs). Purified proteins were dialyzed into 20 mM Tris Tris·HCl pH 8.0, 300 mM NaCl, 10% glycerol, and 2 mM DTT at 4 °C, aliqouted and stored at -80 °C. Prior work expressed Ste7 constructs with an N-terminal GST tag (11) . In this work, we switched to an MBP tag to obtain higher purity protein and to eliminate any potential artifacts from GST dimerization (13, 14) . MBP-Ste7EE and GST-Ste7EE were found to have a similar k cat for Fus3 phosphorylation (in reactions with Ste5), 1 and the K act for Ste5 binding was ~5-fold weaker for MBP-Ste7EE than for GST-Ste7EE. 2 In the previous work, a variant of Ste7 with a single docking site for Fus3 was used (mutant Ste7EE-ND2 has the second, weaker docking site removed (15) ). There was no difference in the behavior of Ste7EE and Ste7EE-ND2 for the kinetic parameters reported in this work.
Selection of a Ste5 PH Domain-Specific Fab
A minimal PH domain construct of Ste5 (Ste5 367-525 ) was expressed as a GST fusion protein with a C-terminal His-tag and affinity purified on Ni-NTA (Qiagen), followed by glutathione agarose (Sigma). As a negative control for selection, free GST with the Cterminal His tag (GST His ) was also purified as above.
We used a phage-displayed scFv library with a diversity of greater than 10 11 unique clones and randomized at all 6 complementarity determining regions (CDRs). The library was built from an scFv scaffold that binds E. coli maltose binding protein, using methods previously described (16) . Selection of domain-specific scFv sequences was performed as described (17) . Briefly, 96-well Maxisorp Immunoplates (Fisher Scientific) were coated with 5 µg/mL GST-tagged Ste5 367-525 or GST His in phosphate buffered saline (PBS). At each round of selection, phage that bound non-specifically were cleared by incubation on GST His and unbound phage was transferred to the antigen-coated wells and allowed to incubate for 2 hours at room temperature. Wells were washed 10 times with PBS + 0.05% Tween-20. Bound phage was eluted with 0.1 N HCl and neutralized with 1 M Tris·HCl (pH 8.0) and used to infect actively growing E. coli XL1-Blue cells (Agilent Technologies) for overnight propagation. After five rounds of selection, phage particles were produced from individual clones and used in phage ELISAs to detect specifically binding clones. Positive clones were sequenced and the CDRs for unique clones were grafted onto an IPTG-inducible Fab scaffold using previously described methods (18) .
The SR13 Fab protein was expressed in E. coli 55244 cells in 2YT with 100 µg/mL carbenicillin. Cells were grown to OD 600 0.8 before inducing with 1 mM IPTG for 16 h at 30 °C. Cells were resuspended in lysis buffer (1 mg/mL lysozyme, 37.5 U/mL benzonase, 2 mM MgCl 2 , 0.2 mM PMSF) and incubated on ice for 1 h. The crude lysate was spun down and the supernatant was applied to an rProtein A affinity column (GE Healthcare), washed with 25 column volumes of PBS, eluted with elution buffer (50 mM NaH 2 PO 4 , 100 mM H 3 PO 4 , 140 mM NaCl, pH 2.0), and neutralized with neutralization buffer (1 M Na 2 HPO 4 , 140 mM NaCl, pH 8.6). Purified protein was concentrated and buffer exchanged to PBS on Amicon Ultracel 10K filter units (Millipore).
In Vitro Kinetic Assays
In vitro kinetic assays were conducted in 25 mM Tris·HCl (pH 8.0), 100 mM NaCl, 2.5 mM MgCl 2 , 0.05% IGEPAL, and 2 mM TCEP at 25 °C. Fus3 phosphorylation reactions were initiated by addition of ATP to a final concentration of 500 µM.
To determine the rate of Ste7 dissociation from Ste5 (k off ), 100 nM Ste5, 100 nM Ste11, 100 nM Ste7EE, and 500 nM Fus3 K42R were pre-incubated in reaction buffer on ice. Dissociation reactions were initiated by introducing a large excess (20 µM) of a Ste7 binding domain (the "sink", a minimal Ste7 binding domain from Ste5 [residues 759-810]), which captures Ste7 as it dissociates from Ste5. After varying times, ATP was added, and reaction timepoints were collected at 15 second intervals by quenching in 4X LDS sample loading buffer (Life Technologies) supplemented with 50 mM EDTA and 2 mM DTT and placing the samples in a boiling heat block (>100 °C) for 90 seconds. Samples were run on NuPAGE 4-12% Bis-Tris gels (Life Technologies) and transferred to nitrocellulose membranes (Whatman Protran BA83).
Quantitative western blots were carried out using a primary anti-phospho p44/p42 MAPK antibody (Cell Signaling Technology #4370) and a secondary IRDye 800CW Goat Anti-Rabbit IgG antibody (Li-Cor #926-32211) using 5% milk as a blocking solution. Blots were visualized using the Li-Cor Odyssey Imaging System and quantified using Odyssey 2.1 software as described previously (11) .
Kinetic parameters and their standard errors were determined by nonlinear leastsquares fitting to initial rate data. The initial rate of Fus3 phosphorylation at each timepoint after addition of the Ste7 binding domain sink corresponds to the amount of Ste5-Ste7-Fus3 complex remaining at each timepoint. k off was determined by fitting to the equation
where t is the time after addition of the sink, V 0 is the initial rate without any sink added and C is a constant to account for weak residual activity due to incomplete capture of Ste7 by the sink. The observed k off of 0.2 s -1 is a lower limit -dissociation occurs on a timescale faster than can be measured with mixing by hand. No change in dissociation rates was observed in the presence or absence of Ste11 (Fig. S1 ).
To determine steady state rate constants (k cat and K M ), the concentration of Fus3 K42R was varied from 10 nM to 1 µM at a constant, saturating concentration of 1 µM Ste5. To determine K act , the concentration of Ste5 was varied from 10 nM to 3 µM at a constant, saturating concentration of 500 µM Fus3 K42R. Reactions were typically conducted at 50 nM Ste7EE. In separate experiments, the concentration of Ste7EE was varied over a >10-fold range from 20-250 nM to confirm that reaction rates scaled linearly with total enzyme concentration.
Plots 
Structure Determination
Crystals of Ste5 582-786 were obtained by mixing 10 mg/mL of protein (1:1 vol:vol) with a solution containing 20% PEG 3350, 0.1 M CaCl 2 , 25 mM Tris·HCl (pH 8.0), in hanging drops at 16 °C. Crystals grew as long rods that reached a maximum size in two days. The cryopreservant for X-ray data collection consisted of mother liquor supplemented with 25% glycerol. Diffraction data was collected in-house on a Rigaku RAxis IV. Diffraction data was processed using XDS (19) . Phases were obtained by molecular replacement with PHASER (20) using Ste5-ms (PDB 3FZE) as a search model. The resulting maps were of excellent quality and the additional density for the N-terminal extension (residues 583-592) was readily visible in difference maps. The preliminary model obtained from molecular replacement was extended to include the additional residues, manually rebuilt in COOT (21) , and refined using PHENIX (22) . Xray diffraction data and refinement statistics are shown in Table S4 .
Structure Homology Modeling
In the model for Ste5 autoinhibition (Fig. 3D) , structures of Ste5 582-786 (PDB 4F2H, this work) and Fus3 (PDB 2B9F (23)) are from experimental data. The structure of the Ste7 kinase domain was modeled from the structure of a homologous mammalian MAPKK (MKK7, PDB 2DYL). The Ste5 PH domain (residues 367-518) was modeled from the structure of a homologous PH domain from rat PLCδ (PDB 1MAI (24)). Homology models were generated using the threading program Phyre (25) .
PH Domain Inhibition Experiments
For the in trans inhibition experiments, purified tag-free Ste5 PH domain (367-525) was exchanged into 25 mM Tris·HCl (pH 8.0), 100 mM NaCl, 2.5 mM MgCl 2 , 0.05% IGEPAL, and 2 mM TCEP at 25 °C with a 7K MWCO Zebra 0.5 mL desalting column (Thermo Scientific). Varying concentrations of the PH domain were incubated with Ste5 VWA domain constructs (1 µM) for 30 minutes at room temperature prior to the addition of 50 nM Ste7EE and saturating (1 µM) Fus3 K42R. Reactions were initiated with 500 µM ATP at 25 °C and initial rates were determined by quantitative western blot as described above. The curves shown in 
Fab Activation Experiments
For Fab activation experiments, purified SR13 Fab was exchanged into 25 mM Tris·HCl (pH 8.0), 100 mM NaCl, 2.5 mM MgCl 2 , and 0.05% IGEPAL. SR13 Fab was incubated at varying concentrations with 1 µM full-length Ste5 for 30 minutes at room temperature before the addition of 50 nM Ste7EE and saturating (1 µM) Fus3. Reactions were initiated with 500 µM ATP at 25 °C and initial rates were determined by quantitative western blot as described above.
Reconstituted Vesicle Experiments
Phosphatidyl choline (PC, egg yolk), PI(4,5)P 2 (brain), and DGS-NTA(Ni) were purchased from Avanti. Unilamellar vesicles were generated by mixing PC with varying quantities of PI(4,5)P 2 and/or DGS-NTA(Ni) dissolved in chloroform in the molar ratios as indicated in Fig. 3G . Mixed lipids were dried under argon, placed under vacuum for 12 hours, and resuspended in 25 mM Tris·HCl (pH 8.0), 100 mM NaCl, and 2.5 mM MgCl 2 to a final concentration of 3.2 mM total lipid. Hydrated lipids were subjected to ten cycles of freezing in liquid nitrogen, thawing, and 1 min bath sonication. Lipids were then extruded through a 0.2 µM filter (Avanti). Approximate concentrations of an indicated lipid species were estimated as the mole fraction of the total lipid concentration divided by 2, assuming 50% of the total was on the inside layer of the vesicles. The resulting vesicles were stored at 4 °C and used in assays within five days of preparation.
For vesicle activation experiments, 500 nM (final reaction concentration) of the Ste5 His-PM-PH-VWA construct (Fig. S13 ) was incubated with lipid vesicles (at ~160 µM lipid concentration) in 25 mM Tris·HCl (pH 8.0), 100 mM NaCl, 2.5 mM MgCl 2 , and 2 mM TCEP for 1 hour at 4 °C. The final lipid concentrations in reactions with 90:5:5 PC:PI(4,5)P 2 :DGS-NTA(Ni) vesicles were approximately 144 µM PC, 8 µM PI(4,5)P 2 , and 8 µM DGS-NTA(Ni). Following incubation, 50 nM Ste7EE and saturating (1 µM) Fus3 were added, the reactions were initiated with 500 µM ATP at 25 °C, and initial rates were determined by quantitative western blot as described above.
Fig. S1
(A) Signaling networks frequently share components. Physical sequestration by scaffold proteins has been proposed as a mechanism for pathway insulation by preventing exchange between distinct pools of signaling proteins. (B) The yeast mating and invasive growth pathways are physiologically distinct inputoutput responses that share two common components -the MAPKKK Ste11 and the MAPKK Ste7. The Ste5 scaffold is essential for signaling through the mating pathway. (C) The dissociation rate of the MAPKK Ste7 from the Ste5 scaffold protein is fast. Dissociation rates were measured with purified recombinant Ste5, the MAPKKK Ste11, the MAPK Fus3, and a constitutively active form of the MAPKK Ste7 (Ste7EE, bearing phosphomimic mutations in the Ste7 activation loop). To a preassembled Ste5-Ste7-Fus3 complex, an excess of a Ste7 binding domain (the "sink", a minimal Ste7 binding domain from Ste5 [residues 759-810]) was added to capture Ste7 as it dissociates from Ste5. After varying times, ATP was added, and the initial rate of Fus3 phosphorylation corresponds to the amount of Ste5-Ste7-Fus3 complex remaining at each timepoint. The observed k off of 0.2 s -1 is a lower limit -dissociation occurs on a timescale faster than can be measured with mixing by hand. There was no detectable difference in the Ste5-Ste7 dissociation rate measured in the presence () or absence () of Ste11.
Fig. S2
Values of k cat were measured for MBP-Ste7EE-catalyzed Fus3 phosphorylation in the absence of Ste5, with full-length Ste5, and with Ste5 VWA-C . Ste5 VWA-C increases k cat by ~10 3 -fold, while full-length Ste5 increases k cat by ~10 2 -fold relative to the reaction in the absence of Ste5. The value of k cat for MBP-Ste7EE in the absence of Ste5 of (8.6 ± 1.5) × 10 -6 is ~10-fold greater than that measured previously with GST-Ste7EE-ND2 (11). (15, 26) . Fitted values of kinetic constants are reported in Table S1 . . Although GST-Ste7EE-ND2 was used in previous work (11), MBP-Ste7EE was used for all data reported in this work because it produced higher purity protein and avoids any potential artifacts arising from GST dimerization (13, 14) . The value of K act of 25 ± 7 nM for GST-Ste7EE-ND2 is an upper limit for K act because it is approximately half of the concentration of Ste7 in the reaction and thus may reflect titration conditions. This value is substantially tighter than the value of 161 nM previously reported for GST-Ste7EE-ND2 binding to Ste5-ms (residues 593-786) (11) because full-length Ste5 contains the complete binding site for Ste7 that extends into the C-terminal tail (27) . The tighter apparent binding by GST-Ste7EE-ND2 could be related to GST dimerization.
The ND2 designation indicates that the second, weak docking site for Fus3 has been removed (15) . There is no difference in the behavior of Ste7EE and Ste7EE-ND2 for the kinetic parameters reported in this work.
Fig. S5
The anti-phospho p44/p42 MAPK antibody (Cell Signaling Technology #4370) preferentially recognizes Fus3PP relative to Kss1PP. The average ratio of Fus3PP to Kss1PP is 2.1 ± 0.2 (± standard deviation, 10 measurements). Recombinant standards of Fus3PP and Kss1PP were prepared from proteins purified as described (11) and phosphorylated to completion with Ste7EE (and Ste5 VWA-C for Fus3). The standards were loaded in equimolar quantities and analyzed by western blot using the anti-phospho p44/42 MAPK antibody (Cell Signaling Technology #4370). Band intensities were quantified using Li-Cor Odyssey 2.1 software.
Fig. S6
(A) Schematic diagram of full-length Ste5 and truncation mutants. Ste5 VWA-C is the minimal VWA domain plus the C-terminal tail that includes the complete Ste7 binding region (27) . Ste5-ms is the minimal VWA domain (residues 593-786, previously described in (11)). Ste5∆(544-592) is an internal truncation that is autoinhibited in vitro (Fig. 3A and 3B fig. S5 and normalized to PGK loading control.
Fig. S9
Ste5 contains several well-characterized domains, including the PM helix, which facilitates membrane binding and mediates cell-cycle regulation of Ste5 activity (29, 30) ; the RING-H2 domain, which binds Gβ (Ste4) to localize Ste5 to the membrane when the pathway is stimulated (31); the Fus3-binding domain (FBD), which is not required for Fus3 activation but instead serves a feedback regulatory role (26, 36) ; the PH domain, which binds to phosphoinositol 4,5-bisphosphate (PI(4,5)P 2 ) to facilitate Ste5 membrane binding (32) and also includes the binding site for the MAPKKK Ste11 (27) ; and the VWA domain, which binds Ste7 and co-catalyzes Fus3 phosphorylation (11) . The Ste7 binding site extends past the VWA domain into the C-terminal tail (27) . We found that the PM-helix, RING-H2 domain, and FBD were dispensable for Ste5 autoinhibition. In contrast, truncation beyond the PH domain or internal deletion of the PH domain eliminated inhibition.
Truncation and internal deletions of Ste5 were purified to homogeneity and kinetic parameters for in vitro coactivator function were determined for each variant. Our model for inhibition is consistent with and suggests an explanation for the phenotype of a previously identified allele of Ste5 (S770N) that activates Fus3 in the absence of pheromone (37, 38) . Ser770 lies on the same face of the VWA as the N-terminal helix, packs up against it, and orients its backbone carbonyl to make a hydrogen bond with Lys603. Disruption of this interaction in the S770N mutant likely destabilizes the binding site for the PH domain, and prevents Ste5 from adopting an autoinhibited conformation. Consistent with this prediction, we find that the S770N allele of Ste5 displays uninhibited coactivator activity in vitro and, furthermore, is inhibited less potently by the PH domain in trans. (Fig. 3G) .
Fig. S14
Dimerization of Ste5 has been suggested to be important for mating pathway activation in vivo (31, (37) (38) (39) (40) , and this effect may act at the level of Ste11 activation (31, (37) (38) (39) , upstream of activation of the mating MAPK Fus3. Although we cannot exclude a role for Ste5 dimerization in the relief of autoinhibition of the VWA domain, we find no evidence supporting this possibility.
Key evidence supporting a role for dimerization of Ste5 in mating pathway activation comes from the observation that GST-tagged Ste5 leads to constitutive pathway activation in the absence of the mating input (α-factor) (31, (37) (38) (39) . GST is known to form a dimer (13, 14) . To test whether artificial dimerization of Ste5 with a GST tag could relieve autoinhibition of the VWA domain, we measured rate constants for a GSTtagged Ste5 construct in vitro, but no relief of autoinhibition was observed (Fig. S14A) .
The extended Ste5 VWA domain (Ste5 582-786 ) is a dimer (Fig. S14B and C) . Because the dimerization interface partially overlaps with features required for PH domain binding and inhibition (Fig. 3) (B) Phosphorylation of MAP kinases in response to α-factor monitored by anti-phospho western blotting. There is no α-factor response in a ∆Ste11∆Ste20 strain, and restoring wild type Ste11 has no significant effect. Introduction of Ste11∆N, Ste11-4, or Ste11-3D, which are constitutively-active alleles of the MAPKKK Ste11 (33, 41, 42) , leads to significant Fus3 activation. Ste11∆N is an amino-terminal truncation that renders the kinase constitutively-active (41) and also lacks the Ste5 binding site (43) . This allele is therefore the most informative for assessing whether α-factor treatment activates Ste5 for the Ste7Fus3 reaction (rather than the Ste11Ste7 reaction). Ste11-4 and Ste11-3D contain point mutants that activate the kinase (33, 42) . Ste11∆N was overexpressed from an Adh1 promoter to compensate for the relatively weak activity of this allele, and all other Ste11 constructs were expressed from the Ste11 promoter (Table S3 ). The stronger basal Fus3 activation observed with Ste11-4 and Ste11-3D is likely to be a consequence of the comparatively strong constitutive activity of these alleles relative to that of Ste11∆N.
(C) The change in Fus3PP levels +/-α-factor is similar for all three constitutive Ste11 alleles. Table S1 . Kinetic constants for Fus3 phosphorylation reactions. Fig. 2 for data and Methods for kinetic models used to fit the data. The k cat with Ste5 VWA-C is 10-fold larger than with full-length Ste5, while K act is unchanged. The K M is approximately 4-fold weaker for full-length Ste5, but this is likely due to the presence of an additional binding site for the Fus3 substrate within the full-length Ste5 which can titrate out substrate (15, 26) . Standard errors are from non-linear least squares fits to the initial rate data. 
